Clinical trial
Nordic-Baltic-British Left Main Revascularization Study (NOBLE)
NCT01496651 is registered in ClinicalTrials.gov with Evald Hoej Christiansen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nordic-Baltic-British Left Main Revascularization Study (NOBLE)
- Lead sponsor
- Evald Hoej Christiansen
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 6, 2008
- Completion date
- December 31, 2025
- Enrollment
- 1,201 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.